These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21351205)

  • 1. Are inherited thrombotic risk factors associated with fibrostenosis in Crohn's disease?
    Novacek G; Papay P; Miehsler W; Reinisch W; Lichtenberger C; Sunder-Plassmann R; Vogelsang H; Gratzer C; Mannhalter C
    Inflamm Bowel Dis; 2011 Dec; 17(12):2505-11. PubMed ID: 21351205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of factor V G1691A (Leiden), prothrombin G20210A, and methylene tetrahydrofolate reductase C677T thrombophilic mutations in children with inflammatory bowel disease.
    Kader HA; Berman WF; Al-Seraihy AS; Ware RE; Ulshen MH; Treem WR
    J Pediatr Gastroenterol Nutr; 2002 Nov; 35(5):629-35. PubMed ID: 12454577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Factor V Leiden, Prothrombin G20210A, MTHFR C677T and MTHFR A1298C gene polymorphisms in retinopathy of prematurity in a Turkish cohort.
    Aydin H; Gunay M; Celik G; Gunay BO; Aydin UT; Karaman A
    Ophthalmic Genet; 2016 Dec; 37(4):415-418. PubMed ID: 27018927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.
    Nishank SS; Singh MP; Yadav R
    Eur J Haematol; 2013 Nov; 91(5):462-6. PubMed ID: 23992124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.
    Mueller T; Marschon R; Dieplinger B; Haidinger D; Gegenhuber A; Poelz W; Webersinke G; Haltmayer M
    J Vasc Surg; 2005 May; 41(5):808-15. PubMed ID: 15886665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients.
    Yasa MH; Bolaman Z; Yukselen V; Kadikoylu G; Karaoglul AO; Batun S
    Hepatogastroenterology; 2007; 54(77):1438-42. PubMed ID: 17708272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor V Leiden G1691A, Prothrombin G20210A, and MTHFR C677T and A1298C Mutations in Patients With Sickle Cell Disease in Tunisia.
    Belhaj Nefissi R; Doggui R; Ouali F; Messaoud T; Gritli N
    Hemoglobin; 2018 Mar; 42(2):96-102. PubMed ID: 30200836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of thrombophilic genes mutations on thrombosis risk in Egyptian nonmetastatic cancer patients.
    Wahba MA; Ismail MA; Saad AA; Habashy DM; Hafeez ZM; Boshnak NH
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):309-15. PubMed ID: 25565385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.
    Almawi WY; Tamim H; Kreidy R; Timson G; Rahal E; Nabulsi M; Finan RR; Irani-Hakime N
    J Thromb Thrombolysis; 2005 Jun; 19(3):189-96. PubMed ID: 16082606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The frequency of factor V Leiden and concomitance of factor V Leiden with prothrombin G20210A mutation and methylene tetrahydrofolate reductase C677T gene mutation in healthy population of Denizli, Aegean region of Turkey.
    Kabukcu S; Keskin N; Keskin A; Atalay E
    Clin Appl Thromb Hemost; 2007 Apr; 13(2):166-71. PubMed ID: 17456626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 19-bp deletion of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) C677T, Factor V Leiden, prothrombin G20210A polymorphisms in cancer patients with and without thrombosis.
    Eroglu A; Egin Y; Cam R; Akar N
    Ann Hematol; 2009 Jan; 88(1):73-6. PubMed ID: 18682947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor V Leiden, prothrombin G20210A and MTHFR gene mutations in inflammatory bowel disease.
    Törüner M; Erkan O; Soykan I; Bozdayi M; Cetinkaya H; Yurdaydin C; Uzunalimoğlu O; Ozden A
    Turk J Gastroenterol; 2004 Dec; 15(4):250-2. PubMed ID: 16249980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of the glycoprotein Ia 807TT, methylene tetrahydrofolate reductase 677TT and prothrombin 20210GA genotypes to prothrombotic risk among factor V 1691GA (Leiden) carriers.
    Hessner MJ; Dinauer DM; Luhm RA; Endres JL; Montgomery RR; Friedman KD
    Br J Haematol; 1999 Jul; 106(1):237-9. PubMed ID: 10444193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombophilia and venous thromboembolism in pregnancy: a meta-analysis of genetic risk.
    Ziakas PD; Poulou LS; Pavlou M; Zintzaras E
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():106-11. PubMed ID: 26115054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of allelic variants of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase with thrombosis or ocular involvement in Behçet's disease: a systematic review and meta-analysis.
    Chamorro AJ; Marcos M; Hernández-García I; Calvo A; Mejia JC; Cervera R; Espinosa G
    Autoimmun Rev; 2013 Mar; 12(5):607-16. PubMed ID: 23207285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor V G1691A, prothrombin G20210A, and methylenetetrahydrofolate reductase [MTHFR] C677T gene polymorphism in angiographically documented coronary artery disease.
    Almawi WY; Ameen G; Tamim H; Finan RR; Irani-Hakime N
    J Thromb Thrombolysis; 2004 Jun; 17(3):199-205. PubMed ID: 15353918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to activated protein C is a risk factor for fibrostenosis in Crohn's disease.
    Novacek G; Miehsler W; Palkovits J; Reinisch W; Waldhör T; Kapiotis S; Gangl A; Vogelsang H
    World J Gastroenterol; 2006 Oct; 12(37):6026-31. PubMed ID: 17009403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in clotting factors and inflammatory bowel disease.
    Bernstein CN; Sargent M; Vos HL; Rosendaal FR
    Am J Gastroenterol; 2007 Feb; 102(2):338-43. PubMed ID: 17156138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in 200 healthy Jordanians.
    Eid SS; Rihani G
    Clin Lab Sci; 2004; 17(4):200-2. PubMed ID: 15559724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between factor V Leiden, prothrombin G20210A, and MTHFR mutations and the first major thrombotic episode in polycythemia vera and essential thrombocythemia.
    Trifa AP; Cucuianu A; Popp RA; Coadă CA; Costache RM; Militaru MS; Vesa ŞC; Pop IV
    Ann Hematol; 2014 Feb; 93(2):203-9. PubMed ID: 23828072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.